| Wednesday, October 17, 2012, Day One |
| 1:30 - 5:45 PM |
Attendees are invited to move from room-to-room |
| Room |
|
| Session Title |
INF. INFORMS / SMDM JOINT PRESENTATIONS
Click to view session |
| 1:30 - 5:40 |
INF-1
(INF) INFORMS/SMDM APPLICATIONS JOINT CLUSTER
INF-1
(INF)
INFORMS/SMDM APPLICATIONS JOINT CLUSTER
|
| Thursday, October 18, 2012, Day Two |
| 9:00 - 10:00 AM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
| Session Title |
KEY. KEYNOTE PRESENTATION - NIRAV R. SHAH, MD, MPH, NEW YORK STATE HEALTH DEPARTMENT
Click to view session |
| 9:00 - 10:00 |
KEY-1
(HSP) BUILDING A HEALTHCARE ECOSYSTEM
KEY-1
(HSP)
BUILDING A HEALTHCARE ECOSYSTEM
|
| 10:30 - 12:00 PM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
Regency Ballroom C |
| Session Title |
TRA1. TOP-RANKED ABSTRACTS, CONCURRENT PRESENTATION 1
Click to view session |
TRA2. TOP-RANKED ABSTRACTS, CONCURRENT PRESENTATION 2
Click to view session |
| 10:30 - 10:48 |
TRA1-1
(DEC,
INF) IMPROVING PHYSICIAN PRESCRIBING DECISIONS..
TRA1-1
(DEC,
INF)
IMPROVING PHYSICIAN PRESCRIBING DECISIONS THROUGH USER INTERFACE REDESIGN
|
TRA2-1
(INF,
HSP) REAL-TIME PREDICTIVE MODELING TO STRATIFY RISK..
TRA2-1
(INF,
HSP)
REAL-TIME PREDICTIVE MODELING TO STRATIFY RISK FOR ALL ADULT INPATIENTS TO REDUCE HOSPITAL READMISSIONS
|
| 10:48 - 11:06 |
TRA1-2
(DEC) WHAT'S IN A NAME? THE INFLUENCE OF A DISEASE..
TRA1-2
(DEC)
WHAT'S IN A NAME? THE INFLUENCE OF A DISEASE LABEL ON A PARENT'S DECISION TO MEDICATE A FUSSY BABY
|
TRA2-2*
(INF,
AHE) ESTIMATING THE COST-EFFECTIVENESS OF XPERT..
TRA2-2*
(INF,
AHE)
ESTIMATING THE COST-EFFECTIVENESS OF XPERT MTB/RIF: APPLYING A BAYESIAN CALIBRATION APPROACH TO A DYNAMIC TB-HIV EPIDEMIC MODEL
|
| 11:06 - 11:24 |
TRA1-3
(DEC) THE EFFECT OF EMOTION AND PHYSICIAN COMMUNICAT..
TRA1-3
(DEC)
THE EFFECT OF EMOTION AND PHYSICIAN COMMUNICATION BEHAVIORS ON SURROGATES' LIFE-SUSTAINING TREATMENT DECISIONS: A RANDOMIZED TRIAL
|
TRA2-3*
(INF,
AHE) THE EFFECT OF PREHOSPITAL PROVIDER TRIAGE..
TRA2-3*
(INF,
AHE)
THE EFFECT OF PREHOSPITAL PROVIDER TRIAGE ACCURACY ON THE COST-EFFECTIVENESS HELICOPTER SCENE TRANSPORT FOR TRAUMA
|
| 11:24 - 11:42 |
TRA1-4
(INF,
DEC) MODELING PERSONALIZED RANK ORDER OF PREVENTIVE..
TRA1-4
(INF,
DEC)
MODELING PERSONALIZED RANK ORDER OF PREVENTIVE CARE GUIDELINES
|
TRA2-4*
(MET) USE OF BAYESIAN BIVARIATE RANDOM-EFFECTS..
TRA2-4*
(MET)
USE OF BAYESIAN BIVARIATE RANDOM-EFFECTS META-ANALYSIS TO EXPLORE UNCERTAINTY IN THE TREATMENT EFFECT OF VITAMIN K ON BONE MINERAL DENSITY AND FRACTURES
|
| 11:42 - 12:00 |
TRA1-5
(HSP) AN INFUENZA VACCINATION POLICY BASED ON A..
TRA1-5
(HSP)
AN INFUENZA VACCINATION POLICY BASED ON A PREVIOUS YEAR'S ILLNESS
|
TRA2-5
(INF,
MET) CALIBRATION METHODS FOR EXPOSURE TO TIME-VARYI..
TRA2-5
(INF,
MET)
CALIBRATION METHODS FOR EXPOSURE TO TIME-VARYING, MODIFIABLE RISK FACTORS: THE EXAMPLE OF SMOKING INITIATION AND QUITTING IN INDIA
|
| 12:45 - 1:30 PM |
Attendees are invited to move from room-to-room |
| Room |
Sundance |
| Session Title |
RFF1. REPORTS FROM THE FIELD 1:
Click to view session |
| 12:45 - 1:00 |
RFF1-1
(HTA) REPORTS FROM THE FIELD, ONC HITECH - VISIONS..
RFF1-1
(HTA)
REPORTS FROM THE FIELD, ONC HITECH - VISIONS FOR THE FUTURE OF HEALTH INFORMATION
|
| 1:30 - 3:00 PM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
Regency Ballroom C |
Regency Ballroom D |
| Session Title |
A. LUSTED FINALIST ABSTRACTS: DECISION PSYCHOLOGY AND SHARED DECISION MAKING
Click to view session |
B. GUIDELINES AND MEASUREMENT OF HEALTH DECISION MAKING
Click to view session |
C. METHODOLOGICAL ADVANCES IN HEALTH DECISION MAKING
Click to view session |
| 1:30 - 1:45 |
A-1*
(DEC) DEVELOPMENT OF AN INTERNET-BASED PATIENTS'..
A-1*
(DEC)
DEVELOPMENT OF AN INTERNET-BASED PATIENTS' DECISION AID FOR SURGICAL VERSUS NONSURGICAL MANAGEMENT OF KNEE OSTEOARTHRITIS
|
B-1
(INF,
HSP) OPTIMIZATION OF FOLLOW-UP GUIDELINES FOR..
B-1
(INF,
HSP)
OPTIMIZATION OF FOLLOW-UP GUIDELINES FOR CLINICAL MANAGEMENT OF PULMONARY NODULES USING A LUNG CANCER MODEL
|
C-1
(INF,
MET) DON'T USE A LOT WHERE A LITTLE WILL DO: A..
C-1
(INF,
MET)
DON'T USE A LOT WHERE A LITTLE WILL DO: A MINIMAL INFORMATION DECISION-ANALYTIC APPROACH TO EARLY HTA OF DIAGNOSTIC TESTS
|
| 1:45 - 2:00 |
A-2*
(DEC) WOMEN'S RESPONSES TO INFORMATION ABOUT..
A-2*
(DEC)
WOMEN'S RESPONSES TO INFORMATION ABOUT OVERDIAGNOSIS IN MAMMOGRAPHY SCREENING
|
B-2
(INF,
AHE) EXAMINING PARAMETERS THAT IMPACT INCREMENTAL..
B-2
(INF,
AHE)
EXAMINING PARAMETERS THAT IMPACT INCREMENTAL COST-EFFECTIVENESS RATIOS
|
C-2
(MET) MULTIPLE IMPUTATION METHODS FOR HANDLING..
C-2
(MET)
MULTIPLE IMPUTATION METHODS FOR HANDLING MISSING DATA IN COST-EFFECTIVENESS ANALYSES: AN APPLICATION TO CLUSTER RANDOMISED TRIALS
|
| 2:00 - 2:15 |
A-3*
(DEC) RADICAL SURGERY VERSUS RADICAL RADIATION FOR..
A-3*
(DEC)
RADICAL SURGERY VERSUS RADICAL RADIATION FOR ADVANCED BLADDER CANCER: A DECISION ANALYSIS
|
B-3*
(AHE) ASK A DIFFERENT QUESTION, GET A DIFFERENT..
B-3*
(AHE)
ASK A DIFFERENT QUESTION, GET A DIFFERENT ANSWER: ISOLATING THE INFLUENCE OF VARIATION IN THE DESCRIPTIVE SYSTEMS OF THE EQ-5D AND SF-6D
|
C-3
(MET) JOINTNESS BOX: A NOVEL METHOD TO CONTEMPLATE..
C-3
(MET)
JOINTNESS BOX: A NOVEL METHOD TO CONTEMPLATE VALUE OF INDIVIDUALIZED CARE FROM TRADITIONAL TRIAL DATA
|
| 2:15 - 2:30 |
A-4*
(INF,
DEC) THE EFFECT OF IMPLICIT VERSUS EXPLICIT..
A-4*
(INF,
DEC)
THE EFFECT OF IMPLICIT VERSUS EXPLICIT DELIBERATIVE GUIDANCE AND THE ROLE OF PATIENTS' DELIBERATIVE STYLES IN INTERACTIVE ONLINE PATIENTS' DECISION AIDS
|
B-4
(HSP) REFERRAL BIAS IN THE DIAGNOSTIC PERFORMANCE OF..
B-4
(HSP)
REFERRAL BIAS IN THE DIAGNOSTIC PERFORMANCE OF EXERCISE TESTING WITH IMAGING FOR CORONARY ARTERY DISEASE
|
C-4
(MET) NEW METHODS FOR INTEGRATING PATIENT PREFERENCE..
C-4
(MET)
NEW METHODS FOR INTEGRATING PATIENT PREFERENCES WITH CLINICAL EVIDENCE
|
| 2:30 - 2:45 |
A-5*
(DEC) PHYSICIAN INNUMERACY IS ASSOCIATED WITH MORE..
A-5*
(DEC)
PHYSICIAN INNUMERACY IS ASSOCIATED WITH MORE ENTHUSIASM FOR CANCER SCREENING
|
B-5
(DEC) PSYCHOMETRIC PROPERTIES OF A NEW MEDICAL RISK..
B-5
(DEC)
PSYCHOMETRIC PROPERTIES OF A NEW MEDICAL RISK SUBSCALE FOR DOSPERT
|
C-5
(MET) COMBINING RANDOM FORESTS AND BAYESIAN GLM FOR..
C-5
(MET)
COMBINING RANDOM FORESTS AND BAYESIAN GLM FOR ESTIMATION OF HETEROGENEOUS TREATMENT EFFECTS
|
| 2:45 - 3:00 |
A-6*
(HSP) INTEGRATING PATIENT PREFERENCES AND CLINICAL..
A-6*
(HSP)
INTEGRATING PATIENT PREFERENCES AND CLINICAL TRIAL DATA IN A BAYESIAN MODEL FOR QUANTITATIVE RISK-BENEFIT ASSESSMENT
|
B-6
(DEC) A RANDOMIZED CONTROLLED TRIAL OF TWO..
B-6
(DEC)
A RANDOMIZED CONTROLLED TRIAL OF TWO PRINCIPLES OF DIAGNOSTIC SUPPORT
|
C-6
(INF,
MET) PROBABILISTIC SENSITIVITY ANALYSIS WITH..
C-6
(INF,
MET)
PROBABILISTIC SENSITIVITY ANALYSIS WITH EFFICIENT SAMPLING TECHNIQUE IN PATIENT-LEVEL SIMULATION MODELS
|
| 3:15 - 4:30 PM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
| Session Title |
SYM1. INVITED SPEAKER SYMPOSIUM: HEALTH INFORMATION TECHNOLOGY CHALLENGES IN AGING PATIENTS
Click to view session |
| 3:15 - 3:16 |
SYM1-1
(AHE) HEALTH INFORMATION TECHNOLOGY CHALLENGES IN..
SYM1-1
(AHE)
HEALTH INFORMATION TECHNOLOGY CHALLENGES IN AGING PATIENTS
|
| 3:16 - 3:41 |
SYM1-2
(AHE) INFORMATICS CHALLENGES IN THE MANAGEMENT OF..
SYM1-2
(AHE)
INFORMATICS CHALLENGES IN THE MANAGEMENT OF PATIENTS WITH MULTIPLE MORBIDITIES
|
| 3:41 - 4:06 |
SYM1-3
(AHE) INTEGRATION OF GENOMICS AND CLINICAL DECISION..
SYM1-3
(AHE)
INTEGRATION OF GENOMICS AND CLINICAL DECISION SUPPORT FOR AGING PATIENTS
|
| 4:06 - 4:30 |
SYM1-4
(AHE) SUMMARY AND DISCUSSION / QUESTIONS
SYM1-4
(AHE)
SUMMARY AND DISCUSSION / QUESTIONS
|
| 4:30 - 6:00 PM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
Regency Ballroom C |
Regency Ballroom D |
| Session Title |
D. SHARED DECISION MAKING AND DECISION SUPPORT INTERVENTIONS
Click to view session |
E. LUSTED FINALIST ABSTRACTS: APPLIED HEALTH ECONOMICS
Click to view session |
F. RISK AND COST EFFECTIVENESS MODELING
Click to view session |
| 4:30 - 4:45 |
D-1
(DEC) TESTING THE ADDED VALUE OF DECISION AID..
D-1
(DEC)
TESTING THE ADDED VALUE OF DECISION AID COMPONENTS TO FACILITATE PATIENTS INFORMED DECISION MAKING ABOUT DIALYSIS TREATMENT OPTIONS
|
E-1*
(INF,
AHE) OPTIMAL INFORMATION ACQUISITION POLICY IN..
E-1*
(INF,
AHE)
OPTIMAL INFORMATION ACQUISITION POLICY IN DYNAMIC HEALTHCARE POLICY: APPLICATION TO HCV SCREENING
|
F-1
(AHE) COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE..
F-1
(AHE)
COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINATION IN THE IMMUNOCOMPROMISED
|
| 4:45 - 5:00 |
D-2
(DEC) AN INTELLIGENT TUTORING SYSTEM TO HELP WOMEN..
D-2
(DEC)
AN INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK
|
E-2*
(AHE) COST EFFECTIVENESS OF DIFFERENT INTERVENTIONS..
E-2*
(AHE)
COST EFFECTIVENESS OF DIFFERENT INTERVENTIONS FOR TREATING PATIENTS WITH NEWLY-DIAGNOSED DIABETIC MACULAR EDEMA
|
F-2
(INF,
HSP) SCREEN MORE OR SCREEN MORE OFTEN? USING..
F-2
(INF,
HSP)
SCREEN MORE OR SCREEN MORE OFTEN? USING MATHEMATICAL MODELS TO INFORM SYPHILIS CONTROL STRATEGIES
|
| 5:00 - 5:15 |
D-3
(DEC) CAN A DASHBOARD BE USED TO MONITOR INFORMED..
D-3
(DEC)
CAN A DASHBOARD BE USED TO MONITOR INFORMED PATIENT CHOICE?
|
E-3*
(AHE) THE COST-EFFECTIVENESS OF MRI IN THE DIAGNOSIS..
E-3*
(AHE)
THE COST-EFFECTIVENESS OF MRI IN THE DIAGNOSIS OF ACUTE APPENDICITIS DURING PREGNANCY: A GUIDE FOR SURGICAL DECISION-MAKING
|
F-3*
(MET) COMBINING REGRESSION ANALYSES AND MARKOV..
F-3*
(MET)
COMBINING REGRESSION ANALYSES AND MARKOV MODELS TO INFER AGE-SPECIFIC MORTALITY RATES BY HEPATITIS C INFECTION AND RISK FACTOR STATUS
|
| 5:15 - 5:30 |
D-4
(DEC) USING INFORMATION TECHNOLOGY TO FACILITATE..
D-4
(DEC)
USING INFORMATION TECHNOLOGY TO FACILITATE SHARED DECISION MAKING FOR PATIENTS ELIGIBLE FOR CANCER SCREENING
|
E-4*
(AHE) COST EFFECTIVENESS OF STEREOTACTIC BODY..
E-4*
(AHE)
COST EFFECTIVENESS OF STEREOTACTIC BODY RADIATION THERAPY FOR MEDICALLY OPERABLE STAGE I NON–SMALL CELL LUNG CANCER
|
F-4
(AHE) COST-EFFECTIVENESS OF MORE FREQUENT HIV..
F-4
(AHE)
COST-EFFECTIVENESS OF MORE FREQUENT HIV SCREENING OF POPULATIONS AT RISK
|
| 5:30 - 5:45 |
D-5
(DEC) NOVEL METHODS TO OVERCOME HEALTH LITERACY..
D-5
(DEC)
NOVEL METHODS TO OVERCOME HEALTH LITERACY BARRIERS TO SHARED DECISION MAKING IN PROSTATE CANCER AMONG LOW-INCOME AFRICAN AMERICAN MEN
|
E-5*
(AHE) A COST-EFFECTIVENESS ANALYSIS OF STATINS FOR..
E-5*
(AHE)
A COST-EFFECTIVENESS ANALYSIS OF STATINS FOR PREVENTING CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
|
F-5
(INF,
MET) AN ALGORITHM FOR STOCHASTICALLY SIMULATING THE..
F-5
(INF,
MET)
AN ALGORITHM FOR STOCHASTICALLY SIMULATING THE CAUSE OF DEATH IN HEART FAILURE PATIENTS
|
| 5:45 - 6:00 |
D-6
(DEC) DOES HEALTH COACHING AFFECT THE DECISION..
D-6
(DEC)
DOES HEALTH COACHING AFFECT THE DECISION PROCESS FOR PATIENTS CHOOSING A SPINAL STENOSIS TREATMENT?
|
E-6*
(AHE) COST-EFFECTIVENESS OF INCREASING CERVICAL..
E-6*
(AHE)
COST-EFFECTIVENESS OF INCREASING CERVICAL CANCER SCREENING COVERAGE AND EFFICIENCY IN LEBANON
|
F-6
(MET) USING SIMULATED DATA TO VALIDATE BAYESIAN..
F-6
(MET)
USING SIMULATED DATA TO VALIDATE BAYESIAN MIXED TREATMENT COMPARISON META-ANALYSIS FOR DIFFERENT EVIDENCE NETWORK PATTERNS AND NUMBERS OF STUDIES
|
| Friday, October 19, 2012, Day Three |
| 8:15 - 8:45 AM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
| Session Title |
PRES. PRESIDENTIAL ADDRESS - OPEN TO ALL ATTENDEES
Click to view session |
| 8:15 - 8:30 |
PRES-1
(INF) SMDM: IN QUEST OF QUALITY
PRES-1
(INF)
SMDM: IN QUEST OF QUALITY
|
| 8:45 - 9:45 AM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
| Session Title |
AWD1. SMDM LEADERSHIP AWARDS - OPEN TO ALL ATTENDEES
Click to view session |
| 8:45 - 9:05 |
AWD1-1
(DEC) SMDM CAREER ACHIEVEMENT AWARD
AWD1-1
(DEC)
SMDM CAREER ACHIEVEMENT AWARD
|
| 9:05 - 9:25 |
AWD1-2
(DEC) SMDM EUGENE L. SAENGER AWARD FOR DISTINGUISHED..
AWD1-2
(DEC)
SMDM EUGENE L. SAENGER AWARD FOR DISTINGUISHED SERVICE
|
| 9:25 - 9:45 |
AWD1-3
(DEC) SMDM JOHN M. EISENBERG AWARD FOR PRACTICAL..
AWD1-3
(DEC)
SMDM JOHN M. EISENBERG AWARD FOR PRACTICAL APPLICATION OF MEDICAL DECISION MAKING RESEARCH
|
| 10:00 - 11:30 AM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
| Session Title |
SYM2. INVITED SPEAKER SYMPOSIUM: BIOMEDICAL INFORMATICS TO ENHANCE CLINICAL AND PUBLIC HEALTH DECISION MAKING
Click to view session |
| 10:00 - 10:01 |
SYM2-1
(HSP) BIOMEDICAL INFORMATICS TO ENHANCE CLINICAL AND..
SYM2-1
(HSP)
BIOMEDICAL INFORMATICS TO ENHANCE CLINICAL AND PUBLIC HEALTH DECISION MAKING
|
| 10:01 - 10:20 |
SYM2-2
(HSP) PUBLIC HEALTH INFORMATICS TO SUPPORT PUBLIC..
SYM2-2
(HSP)
PUBLIC HEALTH INFORMATICS TO SUPPORT PUBLIC HEALTH DECISION MAKING
|
| 10:20 - 10:40 |
SYM2-3
(HSP) NATURAL LANGUAGE PROCESSING FOR AUTOMATIC..
SYM2-3
(HSP)
NATURAL LANGUAGE PROCESSING FOR AUTOMATIC COHORT SELECTION
|
| 10:40 - 11:00 |
SYM2-4
(DEC) HARNESSING CLINICAL RESEARCH INFORMATICS TO..
SYM2-4
(DEC)
HARNESSING CLINICAL RESEARCH INFORMATICS TO SUPPORT CLINICAL DECISION MAKING
|
| 11:00 - 11:20 |
SYM2-5
(HSP) LABORATORY TO PROMOTE/DEVELOP BETTER USABILITY..
SYM2-5
(HSP)
LABORATORY TO PROMOTE/DEVELOP BETTER USABILITY OF CLINICAL SYSTEMS, INTERFACES, EFFECTIVENESS, AND INCORPORATION OF DECISION SUPPORT FOR IMPROVED CARE COORDINATION AND CONTINUITY
|
| 1:00 - 2:30 PM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
Regency Ballroom C |
Regency Ballroom D |
| Session Title |
G. RISK COMMUNICATION AND INDIVIDUAL DECISION MAKING EXPERIENCES
Click to view session |
H. METHODS FOR COMPARATIVE EFFECTIVENESS RESEARCH
Click to view session |
I. LUSTED FINALIST ABSTRACTS: QUANTITATIVE METHODS
Click to view session |
| 1:00 - 1:15 |
G-1
(DEC) BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN..
G-1
(DEC)
BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN PICTOGRAPHS INFLUENCE THE CORRELATION BETWEEN PERCEIVED AND ACTUAL RISK?
|
H-1
(HSP) INFORMING CONSUMERS CHOICE OF HIGH QUALITY..
H-1
(HSP)
INFORMING CONSUMERS CHOICE OF HIGH QUALITY FACILITIES FOR ELECTIVE SURGERY: COMPARING HEALTH PLAN CENTERS-OF-EXCELLENCE DESIGNATIONS WITH PUBLICLY REPORTED QUALITY METRICS
|
I-1*
(MET) ROBUSTNESS OF OPTIMAL MATCHING FOR USE IN..
I-1*
(MET)
ROBUSTNESS OF OPTIMAL MATCHING FOR USE IN EVIDENCE-BASED DECISION ALGORITHMS
|
| 1:15 - 1:30 |
G-2
(DEC) WHY DO I KNOW MORE ABOUT THE LOTTO THAN I DO..
G-2
(DEC)
WHY DO I KNOW MORE ABOUT THE LOTTO THAN I DO ABOUT MY MEDICATIONS? NUMBERS MATTER TO INFORMED PATIENT CHOICES
|
H-2
(HSP) META-ANALYSIS OF REAL-WORLD STUDIES OF..
H-2
(HSP)
META-ANALYSIS OF REAL-WORLD STUDIES OF INITIATING INSULIN GLARGINE VIA DISPOSABLE PEN VERSUS VIAL/SYRINGE AMONG PATIENTS WITH TYPE 2 DIABETES: APPLYING A COMMON DATA STRUCTURE TO A UNIQUE EVIDENCE SYNTHESIS PLATFORM
|
I-2*
(MET) OPTIMIZING GUIDELINES FOR TIMING OF ARTERIOVEN..
I-2*
(MET)
OPTIMIZING GUIDELINES FOR TIMING OF ARTERIOVENOUS FISTULA CREATION IN CHRONIC KIDNEY DISEASE
|
| 1:30 - 1:45 |
G-3
(DEC) PARENTS' ATTITUDES ABOUT THE USE OF RESIDUAL..
G-3
(DEC)
PARENTS' ATTITUDES ABOUT THE USE OF RESIDUAL NEWBORN BLOOD SPOTS FOR RESEARCH
|
H-3
(HSP) A PNEUMONIA MORTALITY MODEL BASED ON HIGHLY..
H-3
(HSP)
A PNEUMONIA MORTALITY MODEL BASED ON HIGHLY DETAILED ADMINISTRATIVE DATA
|
I-3*
(MET) FULLY ADAPTIVE DESIGNS FOR CLINICAL TRIALS:..
I-3*
(MET)
FULLY ADAPTIVE DESIGNS FOR CLINICAL TRIALS: SIMULTANEOUS LEARNING FROM MULTIPLE PATIENTS
|
| 1:45 - 2:00 |
G-4
(DEC) DOES KEEPING IT SIMPLE ACTUALLY HELP? TESTING..
G-4
(DEC)
DOES KEEPING IT SIMPLE ACTUALLY HELP? TESTING THE IMPACT OF THE READING LEVEL OF A DECISION AID ON PROSTATE CANCER DECISION MAKING
|
H-4
(HSP) WHY THE FINDINGS OF PUBLISHED BIOLOGIC..
H-4
(HSP)
WHY THE FINDINGS OF PUBLISHED BIOLOGIC TREATMENT FOR RHEUMATOID ARTHRITIS MULTIPLE TREATMENT COMPARISON META-ANALYSES ARE DIFFERENT: AN OVERVIEW OF RECURRENT METHODOLOGICAL SHORTCOMINGS
|
I-4*
(MET) CALIBRATION METHODS FOR INFERRING TRANSITION..
I-4*
(MET)
CALIBRATION METHODS FOR INFERRING TRANSITION PROBABILITIES FROM CROSS-SECTIONAL STUDIES
|
| 2:00 - 2:15 |
G-5
(DEC) WOMEN'S PREFERENCES REGARDING PRENATAL TESTING..
G-5
(DEC)
WOMEN'S PREFERENCES REGARDING PRENATAL TESTING FOR A RANGE OF GENETIC DISORDERS OF VARYING SEVERITY
|
H-5
(AHE) AN INTEGRATED APPROACH TO EVALUATING..
H-5
(AHE)
AN INTEGRATED APPROACH TO EVALUATING ALTERNATIVE RISK PREDICTION STRATEGIES: A CASE STUDY COMPARING ALTERNATIVE APPROACHES FOR PREVENTING INVASIVE FUNGAL DISEASE
|
I-5*
(MET) OPTIMAL SCREENING STRATEGIES OF PATIENTS ON..
I-5*
(MET)
OPTIMAL SCREENING STRATEGIES OF PATIENTS ON THE KIDNEY TRANSPLANT WAITING LIST
|
| 2:15 - 2:30 |
G-6
(DEC) DETERMINING THE RELATIONSHIP BETWEEN PATIENT..
G-6
(DEC)
DETERMINING THE RELATIONSHIP BETWEEN PATIENT LITERACY AND THE DECISION MAKING EXPERIENCE OF PATIENTS WITH PROSTATE CANCER
|
H-6
(HSP) BARIATRIC SURGERY: A SYSTEMATIC REVIEW AND..
H-6
(HSP)
BARIATRIC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS, 2003-PRESENT
|
I-6*
(MET) OPTIMAL HEALTH PROGRAM INTERVENTION AND..
I-6*
(MET)
OPTIMAL HEALTH PROGRAM INTERVENTION AND INFORMATION ACQUISITION POLICY
|
| 4:00 - 5:30 PM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
Regency Ballroom C |
Regency Ballroom D |
| Session Title |
J. VALUES, PREFERENCE ELICITATION AND UTILITY ASSESSMENT
Click to view session |
K. COST-EFFECTIVENESS ANALYSIS: IMPLICATIONS FOR PREVENTION AND TREATMENT OF DISEASE
Click to view session |
L. LUSTED FINALIST ABSTRACTS D: HEALTH SERVICES & POLICY RESEARCH
Click to view session |
| 4:00 - 4:15 |
J-1
(DEC) BRIEF EDUCATION AND COMPLETING A CONJOINT..
J-1
(DEC)
BRIEF EDUCATION AND COMPLETING A CONJOINT VALUATION SURVEY REDUCE DECISIONAL CONFLICT REGARDING LUNG CANCER SCREENING AMONG INDIVIDUALS AT-RISK FOR LUNG CANCER
|
K-1
(AHE) THE COST-EFFECTIVENESS OF INTEGRATED CERVICAL..
K-1
(AHE)
THE COST-EFFECTIVENESS OF INTEGRATED CERVICAL CANCER PREVENTION STRATEGIES IN THE ONTARIO SETTING – CAN WE DO BETTER?
|
L-1*
(HSP) COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENE..
L-1*
(HSP)
COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF ANTIRETROVIRAL THERAPY AND PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION IN SOUTH AFRICA
|
| 4:15 - 4:30 |
J-2
(DEC) HOLD MY HAND: EXPLICITLY SHOWING TRADEOFFS AND..
J-2
(DEC)
HOLD MY HAND: EXPLICITLY SHOWING TRADEOFFS AND FIT BETWEEN VALUES AND OPTIONS HELPS PEOPLE MAKE CHOICES CONCORDANT WITH THEIR STATED VALUES
|
K-2
(AHE) CERVICAL CANCER SCREENING AND HUMAN PAPILLOMAV..
K-2
(AHE)
CERVICAL CANCER SCREENING AND HUMAN PAPILLOMAVIRUS VACCINATION IN ITALY: A COST-EFFECTIVENESS ANALYSIS
|
L-2*
(HSP) DYNAMIC TRANSMISSION MICROSIMULATION OF..
L-2*
(HSP)
DYNAMIC TRANSMISSION MICROSIMULATION OF TUBERCULOSIS IN INDIA TO ASSESS THE FUTURE IMPACT OF TREATMENT PROGRAMS
|
| 4:30 - 4:45 |
J-3
(DEC) INFORMING ADVANCE DIRECTIVES BY EXPLICITLY..
J-3
(DEC)
INFORMING ADVANCE DIRECTIVES BY EXPLICITLY SIMULATING CARE TRAJECTORIES
|
K-3
(DEC) IS REFUSAL TO TAKE FRACTURE PREVENTION..
K-3
(DEC)
IS REFUSAL TO TAKE FRACTURE PREVENTION MEDICATION SOMETIMES A RATIONAL DECISION? AN EXPLORATORY ANALYSIS THROUGH THE LENS OF COST-EFFECTIVENESS
|
L-3*
(HSP) COMPARING FIFTEEN APPROACHES OF ASSESSING..
L-3*
(HSP)
COMPARING FIFTEEN APPROACHES OF ASSESSING CARDIOVASCULAR DISEASE RISK USING RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE ANALYSIS
|
| 4:45 - 5:00 |
J-4
(DEC) MEASURING FAMILY HRQOL SPILLOVER EFFECTS USING..
J-4
(DEC)
MEASURING FAMILY HRQOL SPILLOVER EFFECTS USING DIRECT HEALTH UTILITY ASSESSMENT
|
K-4
(AHE) MULTIFACTORIAL DECISION MAKING FOR CHEMOTHRAPY..
K-4
(AHE)
MULTIFACTORIAL DECISION MAKING FOR CHEMOTHRAPY IN EARLY-STAGE BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF ONCOTYPE DX
|
L-4*
(HSP) THE WELFARE CONSEQUENCES OF THE DONOR PRIORITY..
L-4*
(HSP)
THE WELFARE CONSEQUENCES OF THE DONOR PRIORITY RULE
|
| 5:00 - 5:15 |
J-5
(DEC) WHAT FACTORS EXPLAIN WILLINGNESS TO TRADE TIME..
J-5
(DEC)
WHAT FACTORS EXPLAIN WILLINGNESS TO TRADE TIME IN THE TIME TRADE-OFF EXERCISES, AND WHAT FACTORS ARE IMPORTANT?
|
K-5
(AHE) COST-EFFECTIVENESS ANALYSIS OF UGT1A1 GENETIC..
K-5
(AHE)
COST-EFFECTIVENESS ANALYSIS OF UGT1A1 GENETIC TESTING TO INFORM INITIAL ANTIRETROVIRAL PRESCRIBING FOR TREATMENT OF HIV IN THE US
|
L-5*
(HSP) COST-EFFECTIVENESS OF SCREENING RESISTANT..
L-5*
(HSP)
COST-EFFECTIVENESS OF SCREENING RESISTANT HYPERTENSIVE PATIENTS FOR PRIMARY ALDOSTERONISM
|
| 5:15 - 5:30 |
J-6
(DEC) ANXIETY AND ACTION BIAS AS PREDICTORS OF..
J-6
(DEC)
ANXIETY AND ACTION BIAS AS PREDICTORS OF PROSTATE CANCER TREATMENT PREFERENCES AND TREATMENT DECISIONS
|
K-6
(HSP) COST-EFFECTIVENESS OF METAL-ON-METAL HIP..
K-6
(HSP)
COST-EFFECTIVENESS OF METAL-ON-METAL HIP RESURFACING COMPARED TO CONVENTIONAL TOTAL HIP ARTHROPLASTY
|
L-6*
(HSP) COST-EFFECTIVENESS OF BLOOD DONOR SCREENING..
L-6*
(HSP)
COST-EFFECTIVENESS OF BLOOD DONOR SCREENING FOR BABESIOSIS IN ENDEMIC REGIONS
|
| 5:30 - 6:15 PM |
Attendees are invited to move from room-to-room |
| Room |
Regency Ballroom A/B |
| Session Title |
AWD2. SMDM EARLY CAREER AWARDS - OPEN TO ALL ATTENDEES
Click to view session |
| 5:30 - 5:45 |
AWD2-1
(DEC) EUROPEAN 2012 MEETING AWARD FOR OUTSTANDING..
AWD2-1
(DEC)
EUROPEAN 2012 MEETING AWARD FOR OUTSTANDING PAPER BY A YOUNG INVESTIGATOR
|
| 5:45 - 6:00 |
AWD2-2
(DEC) US 2012 AWARD FOR OUTSTANDING PAPER BY A YOUNG..
AWD2-2
(DEC)
US 2012 AWARD FOR OUTSTANDING PAPER BY A YOUNG INVESTIGATOR
|
| 6:00 - 6:15 |
AWD2-3
(DEC) SMDM LEE B. LUSTED STUDENT PRIZE AWARD
AWD2-3
(DEC)
SMDM LEE B. LUSTED STUDENT PRIZE AWARD
|
